US NUCLEAR CORP - UCLE STOCK NEWS

US Nuclear (OTC-QB: UCLE) has introduced innovative PFAS monitors in response to new regulations mandating testing for toxic PFAS chemicals. These monitors, both portable and stationary, use proprietary Surface Acoustic Wave technology, offering detection in 5-60 seconds, significantly faster than traditional lab analysis. With states like Maine, New York, and California banning PFAS and imposing strict testing requirements, the demand for US Nuclear's detectors is expected to rise. This development addresses severe health risks posed by PFAS, which contaminates drinking water for millions.

Japan plans to release over 1.3 million tons of tritium-laden water into the Pacific Ocean starting Spring 2023, raising safety concerns globally. US Nuclear Corp (OTC-QB: UCLE) is positioned to provide real-time tritium water monitors to local agencies to ensure safe drinking and seawater standards. These monitors, such as the Model Trimaran-H20, can measure tritium levels below drinking water standards, and are already utilized in various critical facilities. This technology emphasizes US Nuclear's role in potentially mitigating environmental and health risks associated with the water discharge.

On December 13, 2022, Lawrence Livermore National Lab achieved a major milestone by confirming the first-ever net energy gain, or ignition, in nuclear fusion. While this is a significant advancement for green energy, the lab acknowledged that their mega-laser technology cannot be scaled for global electric grids. US Nuclear Corp (OTCQB: UCLE) has been recognized for its collaboration with Livermore Lab and has invested in promising fusion projects such as MIFTI and MIFTEC, which aim to use fusion technology to produce clean energy and medical isotopes.

US Nuclear's strategic partner, Pulmostics Ltd, is advancing early breast cancer detection through innovative breath analysis technology. This non-invasive method aims to match or exceed the sensitivity of traditional mammograms. Currently, Pulmostics is conducting clinical trials at Christus Muguerza hospital in Monterrey, Mexico. With approximately 685,000 breast cancer deaths worldwide in 2022, early detection could significantly improve outcomes. The collaboration with Music Beats Cancer seeks to fund these trials and provide free diagnoses to more women.

US Nuclear Corp. (UCLE) reported financial results for Q3 2022, showing sales of $617,434, down from $683,771 in Q3 2021, but total sales for nine months reached $1,539,517, an increase from $1,454,153 in 2021. Gross margins slightly declined from 47.0% to 45.6%. The net loss improved to $1,671,743 compared to $2,390,256 in the same period last year. Operating expenses decreased by 7.5% due to cost-cutting measures. The company noted heightened demand for its products amidst rising concerns over nuclear and chemical threats, alongside the introduction of advanced detection technologies.

US Nuclear (OTC-QB: UCLE) is addressing global concerns about potential nuclear threats amid the ongoing war in Ukraine. The company highlights the increasing risk of nuclear weapon usage by Russia, especially as it faces significant military losses. US Nuclear's advanced radiation monitoring products are designed to safeguard against radioactive exposure, focusing on vehicle, food, water, and airborne contamination detection. As fears grow, the deployment of these safety tools by individuals and nations worldwide is rising, reinforcing the demand for their innovative solutions.

US Nuclear (OTC-QB: UCLE) has launched the first monitors capable of detecting PFAS chemicals in minutes. PFAS, found in 97% of Americans, are linked to serious health issues. With over 200 million Americans at risk, the new PFAS-FIELD (portable) and PFAS-LAB (stationary) monitors can provide fast results using Surface Acoustic Wave technology. As regulations tighten, awareness of PFAS dangers is growing, driving demand for testing. Maine's new law prohibiting PFAS in products starting in 2030 signals a regulatory shift, benefiting US Nuclear.

US Nuclear (OTC-QB: UCLE) emphasizes the critical role of its radiation monitoring systems amid rising concerns over potential tactical nuclear weapon use by Russia in the ongoing Ukraine conflict. The company's Drone-RAD platform can autonomously track and map radioactive fallout, while its FLG-9000 monitors food items for radioactivity, essential for ensuring public safety. As tensions escalate, these technologies could mitigate risks associated with nuclear fallout, highlighting UCLE's relevance and potential market impact in monitoring and safety sectors.

US Nuclear announced its readiness to enhance safety amid increasing global nuclear threats, notably from Russia and North Korea. The company specializes in radiation monitoring and safety systems, including the DroneRAD product line that uses drones with radiation and chemical sensors to detect hazardous zones. This technology aids in the identification of radioactive hotspots, ensuring the safety of personnel. The press release also includes a disclaimer about forward-looking statements regarding the company's future performance.